The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

REPLY TO THE LETTER TO THE EDITOR

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort

EuroIntervention 2016;12:414. DOI: 10.4244/EIJV12I3A71

1. University Heart Centre Lübeck, University Hospital Schleswig-Holstein, Medical Clinic II, Lübeck, Germany; 2. German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany


We thank the authors for their thoughtful discussion of our analysis1.

First, we agree that the study is underpowered to detect subgroups which may have greater benefit (or harm) from extracorporeal life support (ECLS). This also applies to subgroups which will not profit from ECLS due to a futile clinical situation. The current data should thus be interpreted with caution. As all patients analysed in the current study were in refractory cardiogenic shock (CS) with the likelihood of death deemed to be high in the absence of ECLS, our analysis does not challenge the whole concept of ECLS ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey